Remote monitoring is increasing as new reimbursement paths open up. But even the best programs are no guarantee of success.
Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback